NS · Pharmaceuticals
Pharmaceuticals & Biotechnology
Alembic Pharmaceuticals Ltd (APLLTD) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-11, reported market cap is $152.34B, P/E ratio is 23.79, net margin is 9.7%, dividend yield is 1.42%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Alembic Pharmaceuticals Ltd (APLLTD) has a reported market cap of $152.34B (data as of 2026-07-11).
The price-to-earnings (P/E) ratio for Alembic Pharmaceuticals Ltd (APLLTD) is 23.79 (data as of 2026-07-11).
Alembic Pharmaceuticals Ltd (APLLTD) shows a reported dividend yield of 1.42%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-11).
Alembic Pharmaceuticals Ltd (APLLTD) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
APLLTD is listed on NS.
Alembic Pharmaceuticals Ltd (APLLTD) reports a net margin of 9.7% (data as of 2026-07-11).
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.